Creabilis appoints Dr Simon Russell as Chief Business Officer

07-May-2012 - Luxembourg

Creabilis SA announces that Dr Simon Russell has been appointed as Chief Business Officer. Dr Russell joins Creabilis from Novartis Pharma AG where he held a number global strategic marketing roles and most recently Head of Global Marketing for ILARIS (canakinumab). He was previously Head of Strategic Marketing, Biologics where he was responsible for the introduction of a range of novel methods and commercial strategies across the Novartis biologics portfolio.

Dr Russell joined Novartis from AstraZeneca where, as Global Brand Strategy Director, Biologics he led the team responsible for strategic commercial input to the biologics portfolio in partnership with Cambridge Antibody Technology (CAT) and MedImmune and played a key role in the CAT acquisition. He began his pharmaceutical industry career as a medicinal chemist at ICI Pharmaceuticals and progressed through a number of product, clinical development, marketing and business development roles with Zeneca and AstraZeneca.

Dr Russell has a PhD in organic chemistry from Southampton University and an MA (Hons) in Chemistry from the University of Oxford. He is a member of the Royal Society of Chemistry.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances